Former FDA commissioner Dr. Scott Gottlieb stated Sunday on “Face the Nation” that it’s “certainly reasonable” to start seeing kids aged 5-11 totally vaccinated in opposition to COVID-19 by Thanksgiving.
The FDA’s advisory committee is slated to debate the authorization of the COVID-19 vaccine for kids 5-11 on October 26, shortly after that, the CDC’s committee will meet on November 2 and three to make the ultimate determination on who needs to be eligible for the vaccine, Gottlieb stated.
“Assuming both of those events go well, and you get a positive recommendation out of both the FDA and CDC, this should be available almost immediately after the CDC makes a final recommendation and be available in pharmacies and perhaps pediatricians offices as well,” Gottlieb stated.
Gottlieb, who additionally sits on the board of Pfizer, stated the pharmaceutical company plans to ship the vaccine devoted to kids in each smaller trays and vials with the hope of constructing it extra accessible to pediatric practices
On Thursday, Pfizer turned the primary of the vaccine makers to ask the U.S. authorities to permit use of its COVID-19 vaccine in kids ages 5 to 11.
According to a brand new CBS ballot launched Sunday, greater than a 3rd of oldsters say they’ll vaccinate their 5-to-11-year-olds straight away, and 1 / 4 of oldsters say they’ll wait and see.
Gottlieb stated he’s inspired by the ballot numbers, citing the advantages of getting younger kids vaccinated whereas additionally acknowledging that many dad and mom nonetheless have questions on vaccination.
“There’s a lot of parents that still have a lot of questions around vaccination. I think for them, they should have a conversation with their pediatrician to try to get comfortable with the idea of vaccinating kids,” stated Gottlieb. “We now have the opportunity by the availability of this vaccine to more fully vanquish this virus and protect a broader swath of the population in terms of what CDC is likely to do.”
Gottlieb stated “there’s a lot of information available” for dad and mom, and it “certainly makes me confident about vaccinating my kids.” He urged dad and mom to have a dialogue with their pediatrician in regards to the professionals and cons of vaccination.
For kids youthful than 5, Gottlieb stated medical trials for vaccine approval may start in early 2022.
“Previously, we had talked about trying to have that data available before the end of this year, which could have prompted an authorization, perhaps by the end of the year, at least in kids ages two to four,” Gottlieb stated. “I think it’s more likely that it slips into the first quarter of next year, at the very least, but not too far into next year.”
Download our Free App
For Breaking News & Analysis Download the Free CBS News app